Peritoneovenous Denver Shunt by Potter, Kassidy
Indications and Contraindications
A patient is considered a good candidate if; they meet 
the indications in the chart above, none of the 
contraindications are present, and have healthy 
cardiac and respiratory functions. (Ilia et al, 2017)
Pre-op
Patients lab values are examined at different intervals 
prior to the procedure. These lab values consist of 
blood urea nitrogen (BUN), albumin levels, platelet 
count, bilirubin levels, creatinine levels, lymphocyte 
count, cholesterol levels, exedra (Iida et al, 2017). Lab 
values are taken at 3 weeks preop, one week preop, 
48 hours preop, and finally at 12 hours preop. This is 
to ensure the patient is in good health and remains in 
good health prior to the procedure. It also creates a 
baseline for these values that can be compared to 
after the procedure. The patient has to fast prior to 
the procedure due to the use of conscious sedation. 
(Yarmohammadi et al, 2017)
Placement
The procedure is performed with the patient supine and 
under conscious sedation using local anesthesia. 
Starting with lidocaine, an incision is made above the 
lowest rib on the right, followed by another incision 8-
10 cm below the right hypochondrium. This second 
incision is for access into the peritoneal cavity and is 
determined using sonography. The subcutaneous pocket 
is created on the lowest right rib. The peritoneal cavity 
is drained of ascites to almost completion, leaving 
enough to prime the shunt. If too much fluid is drained, 
saline can be used to prime the shunt. The Fenestrated 
side of the Denver shunt is inserted into the peritoneum 
using a peel-away sheath. Venous access of the right 
subclavian, saphenous, or jugular vein is achieved and 
the catheter is tunneled from the subcutaneous pocket 
to whichever vein is used. Fluoroscopy is used to 
ensure correct length and position. (Ilda et all, 2017) often 
times an antibiotic is also given to the patient to prevent 
any infection. 
Post-op and Follow up 
Patients will often be admitted after the procedure for a 
short time, this is to ensure that no life threatening 
complications present. The patient is told to compress 
the pump 20 times, twice a day in the supine position 
(Yarmohammadi et al, 2017). If no signs of complications 
present the patient will be discharged 72 hrs after the 
completion of the procedure. Within these 72 hours the 
patient’s lab values are checked at 12 hours, 24 hours, 
48 hours, and finally at 72 hours. The patient’s lab 
values are then checked again one week and one month 
after the procedure. Follow-up CT imaging is also 
performed every 3 months to ensure the shunt is still in 
the correct position without any visual complications, 
this is done at least twice and then as needed. Patients 
are informed of signs and symptoms to watch for and to 
contact the IR department immediately if they believe 
something is wrong with the shunt. (Yarmohammadi et al, 
2017)
Peritoneovenous Shunt History
Peritoneovenous shunts have been used to treat ascites 
with Interventional Radiology (IR), for over 50 
years. Being the first in a line of shunts, the Hyde 
shunt was used from 1964-1974. It was improved 
and renamed the LeVeen shunt, being used from 
1974-1979. The LeVeen shunt was then modified, 
creating the popular Denver shunt in 1979. (Ilda, et al, 
2017) Peritoneovenous shunts have been used for the 
same purpose since first developed; treating ascites 
by pumping the fluid within the peritoneal cavity into 
the superior vena cava. This allows the body to 
naturally retain the nutrients within this fluid while 
also expelling it from the peritoneal cavity.
Why the Denver Shunt?
Ascites is the retention of fluid in the peritoneal cavity 
and is one of the most frequent complications of liver 
cirrhosis (failure), occurring in approximately 50% 
of patients with severe liver disease (Caly et al, 2017). 
There are many treatment methods for ascites, some of 
which include multiple paracentesis, a special diet, 
the transjugular intrahepatic portosystemic shunt 
procedure, as well as peritoneovenous shunts. (Caly et 
al, 2017)
How it Works… 
The Denver shunt is available in two sizes. The 11.5 
French shunt is used when the saphenous or 
subclavian veins are used. The 15.5 French shunt is 
used with the internal jugular vein is used. 
The Denver shunt works by having one end of the 
catheter in the peritoneal cavity and the other leading 
to the inferior vena cava. There is then a one way 
valve within a subcutaneous pump that is placed 
anterior to a rib so it can be compressed to move the 
fluid (Farrell & Dennison, 2016, p336). The subcutaneous 
pump is either a single or double valve, the single 
valve provides a faster flow rate than the double 
valve.; though the double valve is more efficient in 
preventing reflux. The double valve, 15.5 French 
shunt is the most commonly used. (Yarmohammadi & 
Getrajdman, 2017) 
Possible complications 
• The most severe complications include pulmonary 
embolism and central venous thrombosis. Both of 
these complications can be life threatening, though 
some can be treated effectively. 
• Disseminated intravascular coagulation or DIC is a 
complication that is often most discussed in relation 
to the Denver shunt. DIC occurs when the ascites 
alters the coagulation in the blood, causing either 
hyperactive or underactive clotting throughout the 
blood stream. (Tamagawa et al, 2020)
• Occlusion of the shunt happens often, being the most 
common complication through various studies (White 
et al, 2011). The use of thrombolytic therapy or the 
replacement of the shunt may be the only two 
solution for occlusion (Tamagawa et al, 2020). The 15.5 
French Denver shunt is less likely to occlude
(Yarmohammadi & Getrajdman, 2017) .
Successes and Removal of Denver Shunt
The Denver shunt has been known to be successful in 
many ascites patients. Due to the shunt being placed 
subcutaneously, the patient is free to shower, swim, 
and perform daily activates once the incisions have 
healed. Many patients need this shunt for many years 
to manage their ascites, though “if imaging can 
confirm the resolution of ascites the shunt can be 
removed” (Yarmohammadi et al, 2017). The removal of the 
shunt is fairly easy with a minimal recovery time. 
(Yarmohammadi et al, 2017)
Conclusion
The findings of this research conclude that the Denver 
shunt, when used on patients who meet the correct 
criteria, is effective in the treatment for ascites. As 
scientists continue to research, there is new 
technology that builds off of the Denver shunt. 
Instead of pumping the ascites fluid into the blood 
stream, it is drained into the bladder. This shunt is 
still experimental, though may be the next step of 
improvement when regarding the treatment of ascites 
using peritoneal shunts. (Jain et al, 2019) IR has used the 
Denver shunts successfully since 1979, it continues 
to bring patients relief of their ascites and give them 
hope of an ascites free future. 
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Indications Relative 
Contraindications
Absolute 
Contraindications
Intractable malignant or 
cirrhotic ascites not 
responding to medical 
treatment and large 
volume paracentesis
Compensated congestive 
heart failure
Blood ascites
Life expectancy of more 
than 3 months
Loculated ascites or 
peritoneal adhesions
Renal failure if the patient 
is not on dialysis
Chylous ascites Peritoneal disease, i.e., 
peritoneal mesothelioma
History of varicose vein 
bleeding
None of the 
contraindication exists
Massive pleural effusion Grade ¾ esophageal 
varices
Varices with no history of 
bleeding
CHF or advanced cardiac 
disease
Portal hypertension Respiratory failure with 
pulmonary edema 
Positive cytology of the 
ascites fluid
Liver failure (T Bili > 2.0 
mg/dL)
Simultaneous 
gastrointestinal surgery
Coagulation disorders 
(Low platelet counts < 50 x 
10^9 or high INR > 2.0
Peritonitis or history of 
spontaneous bacterial 
peritonitis
Evidence of nonsterile 
ascites (from bile leak or 
urine leak)
Poor performance status
Anasarca or 
hypoalbuminemia (serum 
albumin < 2.5 g/dL)
(Yarmohammadi & Getrajdman, 2017)
(White et al, 2011)
(Yarmohammadi & Getrajdman, 2017)
In the left image the arrow is showing the tip of the catheter proximal to the 
right atrium. In the middle image the arrow is showing the compression 
chamber or pump. In the right image the arrow is demonstrating the end of the 
catheter. (Yarmohammadi & Getrajdman, 2017)
(White et al, 2011)
Fenestrated end
(peritoneal end)
Compression 
chamber of shunt
Ascites
CT imaging showing ascites within the peritoneal cavity before and 
after the placement of the Denver shunt. (Won et al, 2008)
